Healthcare • Medical Devices
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if PRCT is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
22 top institutions tracked
Last 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: neutral
Last trade: sell 34 days ago
Red flags: 2
254 filers reported a long position in PRCT for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| BlackRock, Inc. | $110M | 4.9M | +11.6% |
| T. Rowe Price Investment Management, Inc. | $73.7M | 3.3M | -0.2% |
| BNP Paribas Asset Management Holding S.A. | $63.8M | 2.8M | -8.6% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $57.1M | 2.5M | +4.4% |
| VANGUARD CAPITAL MANAGEMENT LLC | $55.6M | 2.5M | +2.6% |
| Chicago Capital, LLC | $46.8M | 2.1M | -4% |
| STATE STREET CORP | $36.5M | 1.6M | +5.7% |
| GEODE CAPITAL MANAGEMENT, LLC | $33.5M | 1.5M | +8.8% |
| FMR LLC | $32.6M | 1.4M | -1.2% |
| PRICE T ROWE ASSOCIATES INC /MD/ | $30.1M | 1.3M | +119.9% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.